Antibiotics only
ApprovedSmall molecule
Antibiotics only is one of 88 small molecule programs targeting Neutropenia. It is currently in Approved.
3
Indications
3
Total Trials
1
Active Trials
87
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
547 competitors in Pneumonia
#DrugCompanyPhaseTrials
1Antibiotics only
GGeorge Washington University
Approved
Primaquine
SanofiPreclinical
Innohep
Alnylam PharmaceuticalsPreclinical
Jakafi
IncytePreclinical
Neutrexin
WWest Japan Thoracic Oncology Group
Preclinical
Virazole
CConrado Roberto Hoffmann Filho
Preclinical
Advil
KKenvue Brands
Preclinical
Cancidas
FFresenius Kabi Oncology Ltd.
Preclinical
Pepcid
KKenvue Brands
Preclinical
Aciphex
Akero TherapeuticsPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Antibiotics only. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Approved[1]
- Company
- GGeorge Washington University